15.66
price down icon1.76%   -0.28
 
loading

Immunovant Inc (IMVT) 最新ニュース

pulisher
04:48 AM

Learn to Evaluate (IMVT) using the Charts - news.stocktradersdaily.com

04:48 AM
pulisher
02:25 AM

Immunovant, Inc. (NASDAQ:IMVT) Receives $38.33 Consensus Target Price from Brokerages - Defense World

02:25 AM
pulisher
Jun 13, 2025

Immunovant: Navigating The Complexities Of The FcRn Landscape (Downgrade) - Seeking Alpha

Jun 13, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Forecasts Immunovant FY2027 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

Immunovant, Inc. (NASDAQ:IMVT) Shares Sold by Wellington Management Group LLP - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Two Sigma Advisers LP Buys New Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Ameriprise Financial Inc. Makes New Investment in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Jun 07, 2025
pulisher
Jun 03, 2025

Immunovant (IMVT) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Jun 03, 2025
pulisher
Jun 02, 2025

Long Term Trading Analysis for (IMVT) - news.stocktradersdaily.com

Jun 02, 2025
pulisher
Jun 02, 2025

Leerink Partnrs Estimates Immunovant FY2030 Earnings - Defense World

Jun 02, 2025
pulisher
May 31, 2025

IMVT Q4 Loss Narrower Than Expected, Stock Up, Pipeline in Focus - MSN

May 31, 2025
pulisher
May 30, 2025

Immunovant price target lowered to $35 from $51 at H.C. Wainwright - TipRanks

May 30, 2025
pulisher
May 30, 2025

Immunovant’s Promising Future: Buy Rating Backed by Strategic Advancements and Strong Cash Position - TipRanks

May 30, 2025
pulisher
May 30, 2025

Immunovant Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 30, 2025
pulisher
May 30, 2025

H.C. Wainwright Adjusts Price Target for Immunovant (IMVT) Amid Future Prospects | IMVT Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Immunovant Insiders Sell US$5.9m Of Stock, Possibly Signalling Caution - simplywall.st

May 30, 2025
pulisher
May 30, 2025

Immunovant (NASDAQ:IMVT) Shares Gap Up After Better-Than-Expected Earnings - Defense World

May 30, 2025
pulisher
May 30, 2025

Immunovant, Inc. Reports Strategic Progress and Financial Results - TipRanks

May 30, 2025
pulisher
May 29, 2025

IMVT INVESTIGATION ALERT: Investigation Launched into Private Placement Transaction by Immunovant, Inc. and Attorneys Encourage Investors to Contact Law Firm - The Malaysian Reserve

May 29, 2025
pulisher
May 29, 2025

Immunovant, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Immunovant Stock Rises On Narrower-Than-Expected Q1 Loss: Retail’s Still On The Fence By Stocktwits - Investing.com India

May 29, 2025
pulisher
May 29, 2025

Immunovant Stock Rises On Narrower-Than-Expected Q1 Loss: Retail’s Still On The Fence - MSN

May 29, 2025
pulisher
May 29, 2025

Immunovant, Inc. SEC 10-K Report - TradingView

May 29, 2025
pulisher
May 29, 2025

Immunovant (IMVT) Secures Strong Financial Position with $714 Million in Cash | IMVT Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunovant's Fiscal Q4 Net Loss Widens - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Earnings Flash (IMVT) IMMUNOVANT INC. Reports Q4 Loss $0.64 Per Share, vs. FactSet Est of $-0.71 - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Immunovant's Clinical Trials Show 74% Success in Myasthenia Gravis, Advancing 6 Disease Programs - Stock Titan

May 29, 2025
pulisher
May 28, 2025

Immunovant (IMVT) to Release Earnings on Wednesday - Defense World

May 28, 2025
pulisher
May 25, 2025

Bank of America Corp DE Buys 114,511 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World

May 25, 2025
pulisher
May 23, 2025

(IMVT) Trading Advice - news.stocktradersdaily.com

May 23, 2025
pulisher
May 21, 2025

IMVT INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into a Private Placement Transaction by Immunovant, Inc. and Encourages Investors to Contact the Firm - Business Wire

May 21, 2025
pulisher
May 21, 2025

Brokerages Set Immunovant, Inc. (NASDAQ:IMVT) Target Price at $38.33 - Defense World

May 21, 2025
pulisher
May 16, 2025

Immunovant, Inc. (NASDAQ:IMVT) Shares Bought by Northern Trust Corp - Defense World

May 16, 2025
pulisher
May 15, 2025

Is Immunovant, Inc. (IMVT) The Most Undervalued Stock With Smart Money Ratings? - Insider Monkey

May 15, 2025
pulisher
May 15, 2025

The Manufacturers Life Insurance Company Has $889,000 Stock Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

May 15, 2025
pulisher
May 14, 2025

Transcript : Immunovant, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 04 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Smart Money Ratings For 20 Most Undervalued Stocks - Insider Monkey

May 14, 2025
pulisher
May 12, 2025

Immunovant Inc (NASDAQ: IMVT) Is The Among Hot Stock Right Now - Stocksregister

May 12, 2025
pulisher
May 11, 2025

Dimensional Fund Advisors LP Sells 58,463 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World

May 11, 2025
pulisher
May 09, 2025

Is Immunovant, Inc. (IMVT) The Best Stock That Will Bounce Back? - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Raymond James Financial Inc. Buys Shares of 20,382 Immunovant, Inc. (NASDAQ:IMVT) - Defense World

May 09, 2025
pulisher
May 08, 2025

11 Stocks That Will Bounce Back According to Analysts - Insider Monkey

May 08, 2025
pulisher
May 06, 2025

Investor’s Delight: Immunovant Inc (IMVT) Closes Weak at 15.22, Down -3.67 - DWinneX

May 06, 2025
pulisher
May 02, 2025

Ins & Outs: Biopharma players shuffle c-suite ranks - BioProcess International

May 02, 2025
pulisher
May 02, 2025

(IMVT) Investment Analysis - news.stocktradersdaily.com

May 02, 2025
pulisher
May 02, 2025

Immunovant, Inc. (NASDAQ:IMVT) Shares Acquired by Wells Fargo & Company MN - Defense World

May 02, 2025
pulisher
May 01, 2025

A company insider recently sold 1,925 shares of Immunovant Inc [IMVT]. Should You Sale? - knoxdaily.com

May 01, 2025
pulisher
May 01, 2025

IMVT’s Stock Market Adventure: -34.80% YTD Growth Amidst Volatility - investchronicle.com

May 01, 2025
pulisher
May 01, 2025

Thyroid Eye Disease Pipeline 2025: MOA, ROA, and Clinical Trial - openPR.com

May 01, 2025
pulisher
May 01, 2025

Thyroid Eye Disease Pipeline 2025: MOA, ROA, and Clinical Trial Insights Explored by DelveInsight | Immunovant Sciences, Novartis, Viridian Therapeutics, Sling Therapeutics, Regeneron Pharma - Barchart.com

May 01, 2025
pulisher
Apr 30, 2025

Perhaps timely catching Immunovant Inc (IMVT) would be a good idea - Sete News

Apr 30, 2025
pulisher
Apr 28, 2025

Immunovant registers shares for selling stockholders - MSN

Apr 28, 2025
pulisher
Apr 28, 2025

Potential Price Increase for Immunovant Inc (IMVT) After Recent Insider Activity - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

Market Watch Highlights: Immunovant Inc (IMVT) Ends on an Downturn Note at 14.72 - DWinneX

Apr 28, 2025
pulisher
Apr 27, 2025

Stock Market Recap: Immunovant Inc (IMVT) Concludes at 14.58, a -7.60 Surge/Decline - DWinneX

Apr 27, 2025
pulisher
Apr 27, 2025

The week in pharma: action, reaction and insight – week to April 25 - The Pharma Letter

Apr 27, 2025
pulisher
Apr 26, 2025

Immunovant, Inc. (NASDAQ:IMVT) Receives $38.33 Average PT from Analysts - Defense World

Apr 26, 2025
$98.73
price up icon 1.91%
$22.82
price down icon 1.17%
$34.84
price down icon 1.22%
$19.78
price down icon 1.88%
$106.57
price up icon 1.57%
biotechnology ONC
$269.63
price down icon 2.50%
大文字化:     |  ボリューム (24 時間):